🚀 ProPicks AI Hits +34.9% Return!Read Now

XPeng remains overweight at Morgan Stanley as sales pick up in February

Published 02/03/2023, 12:02 am
© Reuters
XPEV
-

By Michael Elkins

Morgan Stanley reiterated an Overweight rating and $12.00 price target on XPeng (NYSE:XPEV) after the electric vehicle company reported that it delivered 6,010 units in February, a 15% increase over January’s numbers.

RMB20K-RMB36K ($1 = RMB6.8656) price cuts in mid-January seemed to provide some sales boost to the legacy models as G3, P7, and P5 registered stronger MoM growth while G9 sales stay suppressed at around 1K units (vs.2,249 units in January).

Morgan Stanley analysts wrote in a note, “Management's previous comment of flat QoQ deliveries implies 11K unit sales in March. Volume upside will hinge on the new P7, which will start deliveries later this month. In addition, XPeng’s City NGP (navigation guided pilot) will soon be rolled out on multiple models in a number of cities including Shenzhen and Shanghai. It’s worth monitoring whether the OTA update of CNGP and the launch of G7 turn out to be game-changers.”

Shares of XPEV are down 0.6% in premarket trading on Wednesday.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.